Literature DB >> 23575992

Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity.

Ashley N Fricks-Gleason1, Kristen A Keefe.   

Abstract

Production of nitric oxide (NO) has been implicated in methamphetamine (METH)-induced dopamine (DA) neurotoxicity. The source of this NO has not been clearly delineated, but recent evidence suggests that it arises from activation of neuronal nitric oxide synthase (nNOS), which is selectively expressed in a subpopulation of striatal interneurons. Our objective was to determine whether inhibiting activation of nNOS-containing interneurons in the striatum blocks METH-induced neurotoxicity. These interneurons selectively express the neurokinin-1 (NK-1) receptor, which is activated by substance P. One particular toxin, a conjugate of substance P to the ribosome-inactivating protein saporin (SSP-SAP), selectively destroys neurons expressing the NK-1 receptor. Thus, we examined the extent to which depletion of the nNOS-containing interneurons alters production of NO and attenuates METH-induced neurotoxicity. The SSP-SAP lesions resulted in significant loss of nNOS-containing interneurons throughout striatum. Surprisingly, this marked deletion did not confer resistance to METH-induced DA neurotoxicity, even in areas devoid of nNOS-positive cells. Furthermore, these lesions did not attenuate NO production, even in areas lacking nNOS. These data suggest that nNOS-containing interneurons either are not necessary for METH-induced DA neurotoxicity or produce NO that can diffuse extensively through striatal tissue and thereby still mediate neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575992      PMCID: PMC3692605          DOI: 10.1007/s12640-013-9391-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  45 in total

1.  Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat.

Authors:  J L Li; D Wang; T Kaneko; R Shigemoto; S Nomura; N Mizuno
Journal:  J Comp Neurol       Date:  2000-03-06       Impact factor: 3.215

2.  Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase.

Authors:  S Z Imam; G D Newport; Y Itzhak; J L Cadet; F Islam; W Slikker; S F Ali
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

3.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

4.  The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities.

Authors:  A J Hotchkiss; M E Morgan; J W Gibb
Journal:  Life Sci       Date:  1979-10-15       Impact factor: 5.037

5.  Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.

Authors:  Russell C Callaghan; James K Cunningham; Jenna Sykes; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2011-07-26       Impact factor: 4.492

6.  Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.

Authors:  W A Cass; M W Manning
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

7.  Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine.

Authors:  W A Cass
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

8.  Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats.

Authors:  G Figueredo-Cardenas; M Morello; G Sancesario; G Bernardi; A Reiner
Journal:  Brain Res       Date:  1996-10-07       Impact factor: 3.252

9.  Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.

Authors:  Jing Yu; Jean Lud Cadet; Jesus A Angulo
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

10.  Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.

Authors:  Yossef Itzhak; Karen L Anderson; Syed F Ali
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

View more
  3 in total

Review 1.  Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration?

Authors:  Danielle M Friend; Ashley N Fricks-Gleason; Kristen A Keefe
Journal:  Neurotox Res       Date:  2013-08-06       Impact factor: 3.911

2.  The effect of self-administered methamphetamine on GABAergic interneuron populations and functional connectivity of the nucleus accumbens and prefrontal cortex.

Authors:  Katherine J Robinson; Nicholas A Everett; Sarah J Baracz; Jennifer L Cornish
Journal:  Psychopharmacology (Berl)       Date:  2022-08-03       Impact factor: 4.415

3.  Effects of Intestinal Microbiota on Brain Development in Humanized Gnotobiotic Mice.

Authors:  Jing Lu; Lei Lu; Yueyue Yu; Joanne Cluette-Brown; Camilia R Martin; Erika C Claud
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.